Thomas A Scott, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 975 9th Ave Sw Ste 210, Bessemer, AL 35022 Phone: 205-871-9661 Fax: 205-870-1621 |
News Archive
Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).
There is a pressing need to define accurate maps of global malaria risk if international initiatives to reduce the disease are to be fairly targeted.
A group of researchers critically review the use of surfactant-coated nanoparticles in the fields of nanomedicine and food nanotechnology.
Providing current and vital resources for implementation of health information technology to improve patient care, HIMSS continues to add new information to Meaningful Use OneSource, an online repository of hundreds of documents, tools and links to other knowledge available on the Internet.
› Verified 2 days ago